130 results
Page 3 of 7
20-F
EX-4.17
q38 20ny1
31 Mar 22
Annual report (foreign)
8:09am
20-F
6uuayx9 lw
31 Mar 22
Annual report (foreign)
8:09am
20-F
EX-4.5
rbi1cgi7xa
31 Mar 22
Annual report (foreign)
8:09am
20-F
EX-2.1
2lkzi f8m2kilb
31 Mar 22
Annual report (foreign)
8:09am
6-K
EX-99.1
2r56t7
15 Mar 22
Research report reviews FSD Pharma’s drug development pipeline and operational milestones
6:00am
6-K
EX-99.2
8l96rx1j24fv lrg71
12 Nov 21
Management's Discussion and Analysis of Financial Condition and Results of
9:48pm
6-K
EX-99.1
hprkfwr1y2f5q831
12 Nov 21
Management's Discussion and Analysis of Financial Condition and Results of
9:48pm
6-K
EX-99.1
ocnzuk2xxk txui2uz
27 Sep 21
Material Change Report
12:00am
6-K
EX-99.1
7na0u72rfjb
21 Sep 21
THIS AGREEMENT made as of the 25th day of August, 2021
4:02pm
6-K
EX-99.1
la6jr1acn9prtz92tmm
31 Aug 21
Material Change Report
2:06pm
6-K
EX-99.1
imzru7t jw4nvnoi
25 Aug 21
FSD Pharma Inc. 6-K
9:00am
6-K
EX-99.1
ahg4o5f 5uk
12 Aug 21
Management's Discussion and Analysis of Financial Condition and Results of
9:53pm
6-K
EX-99.2
vupntmvas8mib1
12 Aug 21
Management's Discussion and Analysis of Financial Condition and Results of
9:53pm
6-K
EX-99.1
c9yh9h
27 Jul 21
Appoints Anthony Durkacz as Interim Chief Executive Officer and Reinstates Zeeshan Saeed as President
9:24am
6-K
EX-99.1
8u88lak
3 Jun 21
FSD Pharma Inc. 6-K
9:20am
6-K
EX-99.1
ses397x6pub
10 May 21
FSD Pharma Inc. 6-K
8:30am
6-K
EX-99.1
q3be6vnz0 rpwezux7d
7 May 21
Condensed consolidated interim financial statements
4:38pm
6-K
EX-99.2
v68ytytd0s
7 May 21
Condensed consolidated interim financial statements
4:38pm
6-K
EX-99.1
h4erq kobykzoi2du
5 May 21
FSD Pharma Inc. Form 6-K
5:01pm
6-K
EX-99.1
02n g7hoc
5 May 21
Current report (foreign)
11:30am